These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10609696)

  • 1. Nimodipine in subcortical vascular dementia trial.
    Rossi R; Inzitari D; Pantoni L; del Ser T; Erkinjuntti T; Wallin A; Bianchi C; Badenas JM; Beneke M
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S159-65. PubMed ID: 10609696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is subcortical vascular dementia a clinical entity for clinical drug trials?
    Inzitari D; Erkinjuntti T; Wallin A; del Ser T; Pantoni L
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S66-8. PubMed ID: 10609684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.
    Pantoni L; Rossi R; Inzitari D; Bianchi C; Beneke M; Erkinjuntti T; Wallin A
    J Neurol Sci; 2000 Apr; 175(2):124-34. PubMed ID: 10831773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel blockers and stroke.
    Inzitari D; Poggesi A
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of vascular dementias.
    Inzitari D; Lamassa M; Pantoni L; Basile AM
    Arch Gerontol Geriatr Suppl; 2004; (9):229-34. PubMed ID: 15207419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical findings with nimodipine in dementia: test of the calcium hypothesis.
    Fritze J; Walden J
    J Neural Transm Suppl; 1995; 46():439-53. PubMed ID: 8821080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials of propentofylline in vascular dementia. European/Canadian Propentofylline Study Group.
    Kittner B
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S166-71. PubMed ID: 10609697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
    Rojas-Fernandez CH; Moorhouse P
    Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facts, myths, and controversies in vascular dementia.
    Román GC
    J Neurol Sci; 2004 Nov; 226(1-2):49-52. PubMed ID: 15537519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the pathology of vascular cognitive impairment.
    Jellinger KA
    J Neurol Sci; 2005 Mar; 229-230():57-63. PubMed ID: 15760620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards defining the neuropathological substrates of vascular dementia.
    Kalaria RN; Kenny RA; Ballard CG; Perry R; Ince P; Polvikoski T
    J Neurol Sci; 2004 Nov; 226(1-2):75-80. PubMed ID: 15537525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of nimodipine in elderly dementia patients].
    Damulin IV; Levin OS; Zakharov VV; Zhuchenko TD; Elkin MN
    Ter Arkh; 1995; 67(10):77-9. PubMed ID: 8779117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular dementias].
    Diehl J; Kurz A
    Fortschr Neurol Psychiatr; 2002 Mar; 70(3):145-54. PubMed ID: 11880947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke.
    Nag D; Garg RK; Varma M
    Indian J Physiol Pharmacol; 1998 Oct; 42(4):555-8. PubMed ID: 10874361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia.
    Román GC; Sachdev P; Royall DR; Bullock RA; Orgogozo JM; López-Pousa S; Arizaga R; Wallin A
    J Neurol Sci; 2004 Nov; 226(1-2):81-7. PubMed ID: 15537526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive morphometric and cognitive changes in vascular dementia.
    Gunstad J; Brickman AM; Paul RH; Browndyke J; Moser DJ; Ott BR; Gordon N; Haque O; Cohen RA
    Arch Clin Neuropsychol; 2005 Mar; 20(2):229-41. PubMed ID: 15708732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological treatment of vascular cognitive impairment].
    Bidzan L
    Przegl Lek; 2006; 63(3):131-3. PubMed ID: 16969897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of vascular dementia: evidence from trials with non-cholinergic drugs.
    Pantoni L
    J Neurol Sci; 2004 Nov; 226(1-2):67-70. PubMed ID: 15537523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.
    Pantoni L; Bianchi C; Beneke M; Inzitari D; Wallin A; Erkinjuntti T
    J Neurol Sci; 2000 Apr; 175(2):116-23. PubMed ID: 10831772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.